Full-Time

Associate Manager of Internal Audit

Posted on 8/8/2024

Legend Biotech

Legend Biotech

1,001-5,000 employees

Develops and commercializes cell therapies

Biotechnology
Healthcare

Mid, Senior

Somerset County, NJ, USA

Hybrid position.

Category
Auditing
Accounting
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree from an accredited college / university required
  • Masters, MBA, or CPA, CIA, CISA, CISM strongly preferred
  • Minimum 4 years of experience in auditing (combination of internal and/or external)
  • Experience with Sarbanes-Oxley (SOX) is required
  • Experience in Public Accounting is required
  • Knowledge of U.S. GAAP & IFRS and IIA standards is required
Responsibilities
  • Manage audit risk assessment and develop risk based and value adding audit program via planning and scoping.
  • Manage audit lifecycle from audit planning to audit reporting to meet audit objectives and to ensure compliant, effective and efficient processes and controls are in place:
  • Interview key process owners to assess business processes and the maturity of their control environments.
  • Leverage data analysis in risk assessment and execution of audits.
  • Execute and manage testing procedures that address high risk areas in scope in accordance with Legend Internal Audit and IIA Standards.
  • Identify control gaps, improvement opportunities, and value-added recommendations to strengthen and improve the control environment.
  • Evaluate the risk and potential business impact of identified deficiencies.
  • Document audit workpapers with reperformance standards to include test attributes, associated risks, test conclusions, and opportunities for process improvement.
  • Align audit findings with process owners and operationalize remediation plans.
  • Perform and document walkthroughs and tests of controls to evaluate the effectiveness of the Company’s SOX 404 program.
  • Track identified audit deficiencies/observations and ensure the completion of audit remediations.
  • Collaborate with and help educate process owners on the importance of maintaining strong controls.
  • Build strong relationship with business functions and act as trusted business partner to provide expert insights in the areas of operational audits and SOX audits where the incumbent will review, evaluate and recommend actions to improve control and risk management.
  • Assist department management, including, but not limited to, training and coaching senior and junior auditors. Responsible to prepare evaluations for junior and senior auditor on their projects and will plan an integral part in setting goals and performance objectives.

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates within the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's own cells to combat cancer. Unlike many competitors, Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments. Their goal is to provide effective treatments for hard-to-treat diseases through innovative cell therapy solutions.

Company Stage

IPO

Total Funding

$146.4M

Headquarters

Franklin Township, New Jersey

Founded

2014

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-1%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
  • New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
  • Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

What critics are saying

  • Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
  • Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
  • Financial strain from new R&D facility could affect operational focus if advancements lag.

What makes Legend Biotech unique

  • Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
  • The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
  • Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

INACTIVE